Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Predicting the outcome for pat...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant

Bibliographic Details
Main Authors: Federica Sora, Sabrina Giammarco, Anna Maria Raiola, Carmen Di Grazia, Stefania Bregante, Francesca Gualandi, Riccardo Varaldo, Patrizia Chiusolo, Simona Sica, Luca Laurenti, Idanna Innocenti, Francesco Autore, Elisabetta Metafuni, Eugenio Galli, Andrea Bacigalupo, Emanuele Angelucci
Format: Article
Language:English
Published: Nature Publishing Group 2022-07-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-022-00701-w
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1038/s41408-022-00701-w

Similar Items

  • Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
    by: Andrea Bacigalupo, et al.
    Published: (2021-05-01)
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?
    by: Federica Sorà, et al.
    Published: (2021-10-01)
  • DAYS ALIVE OUTSIDE HOSPITAL AND RE-ADMISSIONS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTS FROM IDENTICAL SIBLINGS, UNRELATED DONORS OR HAPLOIDENTICAL DONORS “.
    by: Federica Sorà, et al.
    Published: (2020-08-01)
  • Extending Long Term Follow-up of Patient With Acute Myeloid Leukemia after Autologous Stem Cell Transplantation: disclosing late mortality and causes of death.
    by: Federica Sorà, et al.
    Published: (2020-04-01)
  • Unrelated cord blood transplantation and post-transplant cyclophosphamide
    by: Andrea Bacigalupo, et al.
    Published: (2019-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs